Reuters -- Myriad Genetics’s fourth-quarter income from continuing operations rose 71 percent and said it was comfortable with the current market estimates for fiscal 2010, sending shares up 7 percent after the bell.
Reuters -- Myriad Genetics’s fourth-quarter income from continuing operations rose 71 percent and said it was comfortable with the current market estimates for fiscal 2010, sending shares up 7 percent after the bell.
